https://www.selleckchem.com/pr....oducts/Staurosporine
event the fruit marketability. © 2020 Society of Chemical Industry. Tocilizumab (TCZ) has been used in the management of COVID-19-related cytokine release syndrome (CRS). Concerns exist regarding the risk of infections and drug-related toxicities. We sought to evaluate the incidence of these TCZ complications among COVID-19 patients. All adult inpatients with COVID-19 between 1 March and 25 April2020 that received TCZ were included. We compared the rate of late-onset infections (48 hours following admission) to a control group
Like
Comment
Share
